Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer

Cancer Letters

Volumn 216, Issue 2, 2004, Pages 157-164

  Ratnasinghe, Luke D ^a   Abnet, Christian ^b   Qiao, You Lin ^c   Modali, Rama ^d   Stolzenberg Solomon, Rachael ^b   Dong, Zhi Wei ^c   Dawsey, Sanford M ^b   Mark, Steven D ^b   Taylor, Philip R ^b  

^a Food/Drug Administration   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d BioServe Biotechnologies Ltd   (United States)

Author keywords

Esophageal cancer; Gastric cardia cancer; Polymorphism; XRCC1

Indexed keywords

ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; BLOOD SAMPLING; CANCER RISK; CARDIA CARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; DNA REPAIR; ESOPHAGUS CANCER; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAZARD ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION; SEX ROLE; STATISTICAL SIGNIFICANCE;

ASIAN CONTINENTAL ANCESTRY GROUP; CARDIA; CHINA; COHORT STUDIES; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; FEMALE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; POLYMORPHISM, GENETIC; RISK; STOMACH NEOPLASMS;

EID: 7744240904     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.03.012     Document Type: Article

References (30)

1. Kubota Y., Nash R.A., Klungland A., Schar P., Barnes D.E., Lindahl: T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. Eur. Mol. Biol. Org. J. 15:1996;6662-6670
2. Lu A.L., Li X., Gu Y., Wright P.M., Chang D.Y. Repair of oxidative DNA damage: mechanisms and functions. Cell Biochem. Biophys. 35:2001;141-170
3. Spitz M.R., McPherson R.S., Jiang H., Hsu T.C., Trizna Z., Lee J.J., Lippman S.M., Khuri F.R., Steffen-Batey L., Chamberlain R.M., Schantz S.P., Hong W.K. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol. Biomarkers Prev. 6:1997;687-692
4. Helzlsouer K.J., Harris E.L., Parshad R., Fogel S., Bigbee W.L., Sanford K.K. Familial clustering of breast cancer: possible interaction between DNA repair proficiency and radiation exposure in the development of breast cancer. Int. J. Cancer. 64:1995;14-17
5. Helzlsouer K.J., Harris E.L., Parshad R., Perry H.R., Price F.M., Sanford K.K., repair D.N.A. proficiency: potential susceptibility factor for breast cancer. J. Natl Cancer Inst. 88:1996;754-755
6. Knight R.D., Parshad R., Price F.M., Tarone R.E., Sanford K.K. X-ray-induced chromatid damage in relation to DNA repair and cancer incidence in family members. Int. J. Cancer. 54:1993;589-593
7. Kovacs E., Almendral A. Reduced DNA repair synthesis in healthy women having first degree relatives with breast cancer. Eur. J. Cancer Clin. Oncol. 23:1987;1051-1057
8. Wu X., Gu J., Amos C.I., Jiang H., Hong W.K., Spitz M.R. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls. Cancer. 83:1998;1118-1127
9. Wei Q., Cheng L., Hong W.K., Spitz M.R. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 56:1996;4103-4107
10. Shen M.R., Jones I.M., Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 58:1998;604-608
11. Lamerdin J.E., Montgomery M.A., Stilwagen S.A., Scheidecker L.K., Tebbs R.S., Brookman K.W., Thompson L.H., Carrano A.V. Genomic sequence comparison of the human and mouse XRCC1 DNA repair gene regions. Genomics. 25:1995;547-554
12. Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., Bell D.A. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 59:1999;2557-2561
13. Bork P., Hofmann K., Bucher P., Neuwald A.F., Altschul S.F., Koonin E.V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. Fed. Am. Soc. Exp. Biol. J. 11:1997;68-76
14. Blot W.J., Li J.Y. Some considerations in the design of a nutrition intervention trial in Linxian People's Republic of China. Natl Cancer Inst. Monogr. 69:1985;9-34
15. Li J.Y., Taylor P.R., Li B., Dawsey S., Wang G.Q., Ershow A.G., et al. Nutrition intervention trials in Linxian. China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J. Natl Cancer Inst. 85:1993;1492-1498
16. Mark S.D., Liu S.F., Li J.Y., Gail M.H., Shen Q., Dawsey S.M., et al. The effect of vitamin and mineral supplementation on esophageal cytology: results from the Linxian Dysplasia Trial. Int. J. Cancer. 57:1994;162-166
17. Blot W.J., Li J.Y., Taylor P.R., Guo W., Dawsey S., Wang G.Q., et al. Nutrition intervention trials in Linxian. China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl Cancer Inst. 85:1993;1483-1492
18. Prentice R.L. A case cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 73:1986;1-11
19. Self S.G., Prentice R.L. Asymptotic distribution theory and efficiency results for case-cohort studies. Ann. Stat. 16:1988;64-81
20. Mark S.D., Katki H. Influence function based variance estimation and missing data issues in case-cohort studies. Lifetime Data Anal. 7:2001;331-344
21. Ratnasinghe D., Yao S.X., Tangrea J.A., Qiao Y.L., Andersen M.R., Barrett M.J., Giffen C.A., Erozan Y., Tockman M.S., Taylor P.R. Polymorphisms of the DNA Repair Gene XRCC1 and Lung Cancer Risk. Cancer Epidemiol. Biomarkers Prev. 10:2001;119-123
22. Preston D.L., Lubin J.H., Pierce D.A., McConney M.E. Epicure. 1988;Hirosoft International Corp, Seattle, WA
23. Stoner G.D., Gupta A. Etiology and chemoprevention of esophageal cancer squamous cell carcinoma. Carcinogenesis. 22:2001;1737-1746
24. Cai L., Zheng Z.L., Zhang Z.F. Risk factors for the gastric cardia cancer: a case-control study in Fujian Province. World J. Gastroenterol. 9:2003;214-218
25. Yu Z., Chen J., Ford B.N., Brackley M.E., Glickman B.W. Human DNA repair systems: an overview. Environ. Mol. Mutagen. 33:1999;3-20
26. Shen M.R., Jones I.M., Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 58:1998;604-608
27. Shen M.R., Zdzienicka M.Z., Mohrenweiser H., Thompson L.H., Thelen M.P. Mutations in hamster single-strand break repair gene XRCC1 causing defective DNA repair. Nucl. Acids Res. 26:1998;1032-1037
28. Xing D., Qi J., Miao X., Lu W., Tan W., Lin D. Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int. J. Cancer. 100:2002;600-605
29. Lee J.M., Lee Y.C., Yang S.Y., Yang P.W., Luh S.P., Lee C.J., Chen C.J., Wu M.T. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int. J. Cancer. 95:2001;240-246
30. Shen H., Xu Y., Qian Y., Yu R., Qin Y., Zhou L., Wang X., Spitz M.R., Wei Q. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int. J. Cancer. 88:2000;601-606